Physician profile
Allyson Nicole Piazza
NPI 1750022760
$1,418.83
in general payments reported to CMS, 2019-2025
16 companies · $684 in 2025
The $684 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $170 · 2024: $565 · 2025: $684.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,419.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,418.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $233.04 | 2023-2025 | Fasenra, Tezspire |
| Verona Pharma, INC. | $228.69 | 2025 | Ohtuvayre |
| Abbvie INC. | $189.68 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $174.45 | 2023-2025 | Dupixent |
| Mylan Specialty L.P. | $97.67 | 2023-2024 | Yupelri |
| Merck Sharp & Dohme LLC | $95.58 | 2024-2025 | Keytruda, Zerbaxa |
| Glaxosmithkline, LLC. | $64.15 | 2023 | Nucala |
| Takeda Pharmaceuticals U.S.A., INC. | $63.65 | 2024-2025 | Glassia |
| Genzyme Corporation | $56.07 | 2024-2025 | |
| Grifols USA, LLC | $46.01 | 2025 | Prolastin-C Liquid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.50 | 2025 | Ofev |
| Baxter Healthcare | $37.13 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Novartis Pharmaceuticals Corporation | $25.69 | 2025 | |
| Electromed, INC. | $24.91 | 2024 | Smartvest |
| Tactile Systems Technology INC | $23.62 | 2025 | Nimbl, Flexitouch Plus |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $15.99 | 2025 | Belbuca |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allyson Piazza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.